Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.4 million.

  • MDxHealth's Free Cash Flow rose 5955.46% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.8 million, marking a year-over-year decrease of 1409.78%. This contributed to the annual value of -$25.9 million for FY2024, which is 1384.58% up from last year.
  • Latest data reveals that MDxHealth reported Free Cash Flow of -$2.4 million as of Q3 2025, which was up 5955.46% from -$1.6 million recorded in Q2 2025.
  • MDxHealth's 5-year Free Cash Flow high stood at $25.2 million for Q2 2022, and its period low was -$17.7 million during Q2 2023.
  • For the 5-year period, MDxHealth's Free Cash Flow averaged around -$3.4 million, with its median value being -$6.3 million (2023).
  • Within the past 5 years, the most significant YoY rise in MDxHealth's Free Cash Flow was 21967.33% (2023), while the steepest drop was 17027.98% (2023).
  • Quarter analysis of 5 years shows MDxHealth's Free Cash Flow stood at -$7.0 million in 2021, then decreased by 27.74% to -$8.9 million in 2022, then rose by 29.52% to -$6.3 million in 2023, then decreased by 7.71% to -$6.8 million in 2024, then surged by 64.97% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$1.6 million for Q2 2025, and -$4.1 million during Q1 2025.